JNJohnson & Johnson JNJ · NYSE
$275.16 +1.52% (+$4.12)
- Market cap
- $662.4B
- Enterprise value
- $691.0B
- P/E
- 41.2x
- Forward P/E
- 23.6x
- PEG
- 0.3x
- P/S
- 6.7x
- P/FCF
- 35.4x
- EV/EBITDA
- 22.4x
- ROIC
- 14.7%
- Gross margin
- 71.3%
- Net margin
- 16.2%
- Dividend yield
- 1.92%
- Payout ratio
- 79.0%
- Net debt/EBITDA
- 0.9x
- Beta
- 0.24
- Free float
- 99.9%
About the company
Johnson & Johnson (JNJ) is a global pharmaceutical, medical, and consumer goods manufacturing company with a diverse portfolio of products. For over 130 years, they have been delivering innovative medicines, medical devices, and consumer products that improve people's lives worldwide. With a strong market position and a history of consistent dividend growth, Johnson & Johnson stock is attractive to conservative investors seeking stable and income-generating returns. Add JNJ stock to your watchlist on Bulios and stay informed about the latest news and innovations from this established company.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato
Employees
141,700
Headquarters
New Brunswick
Valuation
Is today's price reasonable?
- What to watch: You pay 41.2 USD for 1 USD of yearly profit, a lot for its sector.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Earnings per share grew by 18% a year over the last 3 years.
- What to watch: Earnings per share swing sharply from year to year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 16 USD is left as net profit.
- What speaks for it: It earns 15 USD a year on every 100 USD of invested capital.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It has raised its dividend 23 years in a row.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number